Propofol

Half-Life (t½)
IV: 4h
Formula
C12H18O
Molecular Weight
178.27 g/mol
PubChem CID
4943
Aliases
Diprivan

Pharmacological Mechanism

Lipid-soluble GABA-A positive allosteric modulator + glycine receptor potentiation. Workhorse IV induction + maintenance anesthetic; rapid onset (~30 sec) and short duration. Hypotension via vasodilation; "propofol infusion syndrome" (lactic acidosis, rhabdomyolysis) at prolonged high-dose ICU sedation.

Half-Life & Elimination Curve (IV: 4h)

100%50%25%12.5%0%0h0×t½4h1×t½8h2×t½12h3×t½16h4×t½20h5×t½0×t½ (0h): 100% remaining (~10.2 µg/L)1×t½ (4h): 50% remaining (~5.1 µg/L)2×t½ (8h): 25% remaining (~2.55 µg/L)3×t½ (12h): 12.5% remaining (~1.28 µg/L)4×t½ (16h): 6.3% remaining (~0.638 µg/L)5×t½ (20h): 3.1% remaining (~0.319 µg/L)
Elimination (IV)Effect Site (ke0)
  • 0×t½0h100% (10.2 µg/L)
  • 1×t½4h50% (5.1 µg/L)
  • 2×t½8h25% (2.55 µg/L)
  • 3×t½12h12.5% (1.28 µg/L)
  • 4×t½16h6.3% (0.638 µg/L)
  • 5×t½20h3.1% (0.319 µg/L)
Elimination t½4h (IV)
Rate Constant (ke)0.173 h⁻¹
Est. Peak (Cmax)10.2 µg/L
Clearance (CL)34 L/h
97% Washout (5×t½)20h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References